Auna S.A. (AUNA) Cuts 2026 Adjusted EBITDA Outlook to Flat

Auna S.A. revised its 2026 outlook, expecting flat Adjusted EBITDA due to temporary cost pressures from a Colombia payor contract, while revenue growth remains in line with prior guidance.

Original reporting
Published Oct 22, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 12:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Auna S.A. (AUNA) Cuts 2026 Adjusted EBITDA Outlook to Flat — source image
Decision brief

The 30-second read

Med
01

Why it matters

The guidance downgrade suggests margin pressure, which could weigh on the stock until the contract issue is resolved.

02

Market read

Guidance change is material for investors tracking Auna and the broader emerging‑market healthcare sector.

03

What to watch

Details on the Colombia payor contract timeline and its eventual resolution are not disclosed

Relevance 7/10Novelty 7/10Timing: today

Background

Auna S.A. released a preliminary 2026 guidance update indicating revenue growth in line with prior expectations but adjusted EBITDA expected to be flat year‑over‑year due to temporary cost pressure from a Colombia payor contract.

Market effects

adjusted EBITDA outlook may affect healthcare services sector sentiment in Latin America

potential modest impact on Peru and Colombia market participants tracking Auna

limited to investors with exposure to emerging-market health providers

Counterpoint

Flat EBITDA may be temporary; cost pressures could ease faster than expected, offering upside

Key entities

  • Auna S.A.

    Latin American health‑services provider issuing the guidance update

Related articles

$AUNAMed

Auna S.A. (AUNA) Stock Falls on Q3 2026 Earnings

Auna S.A. (AUNA) reported Q3 2026 revenue of $384.7M, up 19.4% YoY, with net income falling 57.4% to $5.9M. Operating cash flow rose 38.9% to $77.6M. Insiders made 6 purchases and 1 sale in the past 6 months. Hedge funds showed mixed activity, with some increasing and others decreasing positions.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q3 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 3Q26 Financial Results Auna reports 10% FX-Neutral Revenue Growth and Continued Strong Cash Generation in 3Q2026; Mexico Returns to Year-over-Year Adjusted EBITDA Growth; Profitability Pressured by Specific Headwinds in Colombia and Peru Leverage Impro

$AUNAHigh

Why is Auna stock dropping today?

Auna SAA ADR stock fell 9.2% to $4.91 after revising its 2026 profitability outlook, citing higher cancer diagnosis costs in Colombia. The company maintained its revenue growth target but saw a sell-off amid broader market declines. The stock dropped to a session low of $4.55, nearing its 52-week low of $4.09.

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$AUNAMed

Auna Q2 Earnings Call Highlights

Auna reported Q2 revenue growth in Mexico (4% YoY), Peru (8%), and Colombia (13%), but adjusted EBITDA varied. Mexico's EBITDA declined 16% YoY due to investments, while Peru's was flat due to billing penalties. Colombia's EBITDA fell 12% YoY but rose 18% sequentially. The company reaffirmed its full-year guidance, expecting 12% FX-neutral revenue growth and adjusted EBITDA growth toward the low end of its 10-14% target range, excluding Peru's billing penalties. Cash flow and leverage improved,